Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Optimi Health Corp C.OPTI

Alternate Symbol(s):  OPTHF

Optimi Health Corp. is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. The Company produces scalable... see more

CSE:OPTI - Post Discussion

Optimi Health Corp > Revenue is on the way
View:
Post by BHstyles on May 04, 2023 11:33am

Revenue is on the way

OPTI announced that it has entered into a CAD$1.2 million definitive supply agreement with a private entity focused on developing mushroom-based therapeutic drugs through pre-clinical research and clinical trials.
Comment by G1945V on Jun 18, 2023 9:49am
https://www.abc.net.au/news/2023-06-17/psychedelics-therapies-insurers-suppliers-cannabis-companies/102477606 Mind Medicine Australia entered into an agreement with a Canadian drug manufacturer, Optimi Health Corp, to supply the new medicines. G1945V
Comment by BHstyles on Jul 04, 2023 2:35pm
Key points about medicinal cannabis companies trying to enter Australia's new psychedelics market:   The Therapeutic Goods Administration (TGA) approved the use of MDMA for post-traumatic stress disorder (PTSD) and psilocybin for treatment-resistant depression, effective from July 1. Only TGA-authorized psychiatrists approved by a human research ethics committee can prescribe these ...more  
Optimi Health Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities